Clinical Trial Update: HCV Treatment Immune Response With Grazoprevir/Elbasvir Before or After Renal Transplant [Phase 4]

View source ↗

Summary

Phase 4 trial updating immune response to grazoprevir/elbasvir when given before or after renal transplant in hepatitis C patients with renal impairment; result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Disorder of Transplanted Kidney
• Hepatitis C
• Renal Insufficiency

Drugs mentioned

• Grazoprevir/Elbasvir

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Hepatitis C, Renal Insufficiency, Chronic | Phase 4 | Status: COMPLETED | Results posted: 2022-11-18